These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 341901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinico-pharmacological studies on the acne-inducing action of fluocortin butylester (author's transl)].
    Wendt H.
    Arzneimittelforschung; 1977; 27(11a):2245-6. PubMed ID: 146498
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of fluocortin butylester on adrenal function in man (author's transl)].
    Wendt H.
    Arzneimittelforschung; 1977; 27(11a):2236-8. PubMed ID: 580036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Synthesis of Butyl 6alpha-Fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-oate (Fluocortin Butylester) (author's transl)].
    Laurent H, Gerhards E, Wiechert R.
    Arzneimittelforschung; 1977; 27(11a):2187-8. PubMed ID: 580026
    [Abstract] [Full Text] [Related]

  • 9. [Dermal and systemic side effects of fluocortin butylester. Comparative skin tearing experiments with active principles from commercial preparations].
    Kapp JF, Gliwitzki B, Josefiuk P, Weishaupt W.
    Arzneimittelforschung; 1977; 27(11a):2206-13. PubMed ID: 580030
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacological studies on butyl 6alpha-fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-oate (fluocortin butylester) (author's transl)].
    Kapp JF, Koch H, Töpert M, Kessler HJ, Gerhards E.
    Arzneimittelforschung; 1977; 27(11a):2191-202. PubMed ID: 580028
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative testing of diflucortolon-21-valerate creme and hydrocortisone-17-butyrate creme in patients with dermatoses].
    Grejs J.
    Ther Ggw; 1978 Dec; 117(12):1930-7. PubMed ID: 725810
    [No Abstract] [Full Text] [Related]

  • 14. [Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].
    Langen M, Hernandez MS.
    Z Hautkr; 1976 Dec; 51 Suppl 1():1-16. PubMed ID: 795179
    [Abstract] [Full Text] [Related]

  • 15. [Experimental toxicity studies on fluocortin butylester in the forms of pure active principle, ointment, fatty ointment and cream in animals (author's transl)].
    Günzel P, Siegmund F, Bhargava AS, El Etreby MF, Lang R, Poggel HA, Schöbel C, Schuppler J, Staben P.
    Arzneimittelforschung; 1977 Dec; 27(11a):2217-21. PubMed ID: 580031
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapeutic effect and effect on the pituitary adrenal functions of fluocortine-butylester in eczema during childhood (author's transl)].
    Favrod-Coune E, Sizonenko PC, Paunier L, Varonier H, Hunziker N.
    Dermatologica; 1978 Dec; 157(5):297-9. PubMed ID: 150351
    [Abstract] [Full Text] [Related]

  • 18. [Use of difluocortolone valerate chlorquinaldol cream in dermatoses with aggregate complications].
    Carvajal Rosado M.
    Prensa Med Mex; 1977 Dec; 42(1-2):100-2. PubMed ID: 331299
    [No Abstract] [Full Text] [Related]

  • 19. [Topical treatment of various dermatoses with 0.1% difluocartolone valerate with 1% chlorquinaldol (cream)].
    Ogarrio González SR.
    Prensa Med Mex; 1977 Dec; 42(1-2):103-5. PubMed ID: 896646
    [No Abstract] [Full Text] [Related]

  • 20. [Difluocortolone valerate for topical use in dermatology].
    Consigli CA, González W.
    Z Hautkr; 1976 Dec; 51 Suppl 1():30-2. PubMed ID: 795184
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.